CAPTRUST FINANCIAL ADVISORS
Position in TMCI — Treace Medical Concepts, Inc.
CIK 1512024
RALEIGH, NC
Position in TMCI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,014
+$169,306 QoQ
Shares Held
52,265
+80.9% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 116 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in TMCI Over Time
Shares Held
Position Value (USD)
Derivatives in TMCI
reported options exposure · as of Jun 30, 2026CallValue
$1,990
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $192,998,899 across 51 Medical Devices names. TMCI ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in TMCI
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,990 | 500 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $208,014 | 52,265 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $38,708 | 28,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,100 | 18,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $98,200 | 14,635 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $62,122 | 10,565 | Shares | Sole | 2025-08-15 | |
| 2023-12-31 | $455,136 | 35,697 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $774,079 | 59,045 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,401,604 | 54,793 | Shares | Sole | 2023-08-15 | |
| 2022-03-31 | $1,210 | 64 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,509 | 81 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||